Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells

Molecular Genetics and Metabolism

Volumn 65, Issue 2, 1998, Pages 155-164

  Jasty, Rama ^a   Lu, Jingyi ^c   Irwin, Todd ^c   Suchard, Suzanne ^b   Clarke, Michael F ^c   Castle, Valerie P ^c,d  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b ASTRAZENECA   (United Kingdom)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Apoptosis; Cellular localization; Neuroblastoma; P53; Radiation resistance

Indexed keywords

DNA FRAGMENT; MUTANT PROTEIN; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IONIZING RADIATION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; TEMPERATURE SENSITIVITY; TUMOR SUPPRESSOR GENE;

EID: 0032191052     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1998.2747     Document Type: Article

References (46)

1. 1. Donehower L, Bradley A. The tumor suppresser p53. Biochim Biophys Acta 1155:181-205, 1993.
2. 2. Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, Bernstein A. High incidence of lung, bone and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 9:3982-3991, 1989.
3. 3. Prokocimer M, Rotter V. Structure and function of p53 in normal cells and their aberrations in cancer cells: Projection on the hematologic cell lineage's. Blood 84:2391-2411, 1994.
4. 4. Yonish-Rouach E, Grunwald D, Wilder S, Kimchi A, May E, Lawrence J, May P, Oren M. p53-mediated cell death: Relationship to cell cycle control. Mol Cell Biol 13:1415-1423, 1993.
5. 5. Ryan J, Danish R, Gottlieb C, Clarke M. Cell cycle analysis of p53-induced death in murine erythroleukemia cells. Mol Cell Biol 13:711-719, 1993.
6. 6. Kastan M, Onyekwere O, Sidransky D, Vogelstein B, Thompson C. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311, 1991.
7. 7. Kuerbitz S, Plunket B, Walsh W, Kastan W. Wild type p53 is a cell cycle checkpoint determinant following radiation. Proc Natl Acad Sci USA 89:7491-7495, 1992.
8. 8. Zhan W, Carrier F, Fornace AJ Jr. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol Cell Biol 13:4242-4250, 1993.
9. 9. Shaulsky G, Goldfinger N, Peled A, Rotter V. Involvement of wild type p53 protein in the cell cycle requires nuclear localization. Cell Growth Differ 9:661-667, 1991.
10. 10. Moll U, Riou G, Levine A. Two distinct mechanisms alter p53 in breast cancer: Mutation and nuclear exclusion. Proc Natl Acad Sci USA 89:7262-7266, 1992.
11. 11. O'Reilly R, Cheung N, Bowman L, Castle V, Hoffer F, Kapoor N, Kletzel M, Lindsley K, Shamberger R, Tubergen D. NCCN pediatric neuroblastoma practice guidelines. Oncology 10:1813-1822, 1996.
12. 12. Ohgaki H, Eibl R, Schwab M, Reichel M, Mariani L, Gehring M, Petersen I, Holl T, Wiestler O, Kleihues P. Mutations of p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinogen 8:74-80, 1993.
13. 13. Gilbert F, Feder M, Balison G, Bronjman D, Lurie D, Podolsky R, Rinaldt V, Vinikoor N, Weisband J. Human neuroblastomas and abnormalities of chromosome 1 and 17. Cancer Res 44:5444-5449, 1984.
14. 14. Vogan K, Bernstein M, Leclerc J, Brisson L, Brossard J, Brodeur G, Pelletier J, Gros P. Absence of p53 gene mutations in primary neuroblastomas. Cancer Res 53:5269-5273, 1993.
15. 15. Imamura J, Bartram C, Berthold F, Harms D, Nakamura H, Koeffler H. Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. Cancer Res 53: 4053-4058, 1993.
16. 16. Davidoff A, Pence J, Shorter N, Iglehart J, Marks J. Expression of p53 in human neuroblastoma-and neuroepithelioma-derived cell lines. Oncogene 7:127-133, 1992.
17. 17. Komuro H, Hayashi Y, Kawamura M, Hayashi K, Kanaka Y, Kamoshita S, Kanada R, Yamamoto K, Kongo T, Yamada M, Tsuchida Y. Mutations of the p53 gene are involved in Ewing's sarcoma but not in neuroblastomas. Cancer Res 53:5284-5288, 1993.
18. 18. Moll U, LaQuaglia M, Bernard J, Riou G. Wild type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci USA 92:4407-4411, 1995.
19. 19. Moll U, Ostermeyer A, Haladay R, Winkfield B, Frazier M, Zambetti G. Cytoplasmic sequestration of wild type p53 protein impairs the G1 checkpoint after DNA damage. Mol Cell Biol 16:1126-1136, 1996.
20. 20. Goldman S, Chen CY, Lansing T, Gilmer T, Kastan M. The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization. Am J Pathol 148: 1381-1385, 1996.
21. 21. Biedler J, Kelson L, Spengler B. Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652, 1973.
22. 22. Martinez J, Georgoff I, Martinez J, Levine A. Cellular localization and cell cycle regulation by a temperature sensitive p53 protein. Genes Dev 5:151-159, 1991.
23. 23. Michalovitz D, Halevy O, Oren M. Conditional inhibition of transformation and of cell proliferation by a temperature sensitive mutant of p53. Cell 62:671-680, 1990.
24. 24. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84:7413-7417, 1987.
25. 25. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 Mutations in human cancers. Science 253:49-53, 1991.
26. 26. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878, 1994.
27. 27. Hansen M, Nielson S, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth and cell kill. J Immunol 119:203-210, 1989.
28. 28. Dole M, Nuñez G, Merchant A, Maybaum J, Rode C, Bloch C, Castle V. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 54:3253-3259, 1994.
29. 29. Oberhammer F, Wilson J, Dive C, Morris I, Hickman J, Wakeling A, Walker P, Sikorska M. Apoptotic death in epithelial cells: Cleavage of DNA to 300 and 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12:3679-3684, 1993.
30. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res 55:2576-2582, 1995.
31. 31. Fukunaga-Johnson N, Ryan JJ, Wicha M, Nuñez G, Clarke MF. Bcl-2 protects murine erythroleukemia cells from p53-dependent and -independent radiation-induced cell death. Carcinogenesis 16:1761-1767, 1995.
32. L by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth Differ 6(4):363-370, 1994.
33. L depends on normal p53 function. Oncogene 13:2287-2293, 1996.
34. 34. Jacobson G, Sause W, O'Brien R. Dose response analysis of pediatric neuroblastoma to megavoltage radiation. Am J Clin Oncol 7:693-697, 1984.
35. 35. Fornace Jr AJ. Mammalian genes induced by radiation: Activation of genes associated with growth control. Annu Rev Genet 26:507-526, 1992.
36. 36. Lowe SW, Schmidt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849, 1993.
37. 37. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852, 1993.
38. 38. Bech-Hansen NT, Blattner WA, Sell BM, McKeen EA, Lampkin BC, Fraumeni JF, Patterson MC. Transmission of in-vitro radioresistance in a cancer-prone family. Lancet 1:1335-1337, 1981.
39. 39. Mirzayans R, Enns L, Dietrich K, Barley RD, Patterson MC. Faulty DNA polymerase δ/∈-mediated excision repair in response to γ radiation or ultraviolet light in p53-deficient fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni. Carcinogenesis 17:691-698, 1996.
40. 40. Lee JM, Abrahamson JLA, Kandel R, Donehower LA, Bernstein A. Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene 9:3731-3736, 1994.
41. 41. Komarova EA, Chernov MV, Franks R, Wang K, Armin G, Zelnick CR, Chin DM, Stark GR, Gudkov AV. Transgenic mice with p53-responsive lac-z: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J 16:1391-1400, 1997.
42. 42. Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA. Phenotypic diversification in human neuroblastoma cells: Expression of distinct neural crest lineages. Cancer Res 49(1):219-225, 1989.
43. 43. Isaacs JS, Hardman R, Corman TA, Selkirk JK, Barrett JC, Weissman BE. p53 exhibits wild-type function in a subset of neuroblastoma cell types. Proc Am Assoc Cancer Res 39:283, 1998.
44. L through caspase interaction. Proc Natl Acad Sci USA 95(2): 554-559, 1998.
45. 45. Fries KL, Miller WE, Raab-Traub N. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol 70(12):8653-8659, 1996.
46. 46. Brian J, Sun Y. p53CP, a putative p53 competing protein that specifically binds to the consensus p53 DNA binding sites: A third member of the p53 family? Proc Natl Acad Sci USA 94:14753-14758, 1997.